Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. NOW
3. TXN
4. TSLA
5. GOOG
6. IBM
7. KNX
8. CSX
9. LVS
10. INTC

Go back to Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Audentes Therapeutics (BOLD) Tops Q2 EPS by 3c

August 6, 2019 4:53 PM EDT

Audentes Therapeutics (NASDAQ: BOLD) reported Q2 EPS of ($1.01), $0.03 better than the analyst estimate of ($1.04).

"It is a very busy time at Audentes, and we are excited by the significant progress we have made across our portfolio," stated Matthew R. Patterson, Chairman and Chief Executive Officer. "Following collaborative interactions with... More